LAVAL, QC, Aug. 31, 2020
/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC)
("Bausch Health" or the "Company") today announced it will reduce
debt by $100 million through the
redemption of outstanding senior notes, using cash generated from
operations.
Bausch Health will redeem $100
million aggregate principal amount of its outstanding 5.875%
Senior Notes due 2023, CUSIP Nos. 91831A AB7, C96729 AB1 (the
"Notes") on Sept. 30, 2020. The
Company will issue today an irrevocable notice of redemption for
the Notes and a copy will be issued to the record holders of such
Notes. Nothing contained herein shall constitute a notice of
redemption of the Notes. Payment of the redemption price and
surrender of the Notes for redemption will be made through the
facilities of the Depository Trust Company in accordance with the
applicable procedures of the Depository Trust Company. The name and
address of the US paying agent are as follows: The Bank of New York
Mellon Trust Company, N.A., c/o The Bank of New York Mellon; 111
Sanders Creek Parkway, East Syracuse,
N.Y. 13057; Attn: Redemption Unit; Tel:
800-254-2826.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, the risks and uncertainties discussed in the Bausch
Health's most recent annual report on Form 10-K and detailed from
time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities
Administrators, which factors are incorporated herein by reference.
They also include, but are not limited to, risks and uncertainties
caused by or relating to the evolving COVID-19 pandemic, and the
fear of that pandemic and its potential effects, the severity,
duration and future impact of which are highly uncertain and cannot
be predicted, and which may have a material adverse impact on
Bausch Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-reduce-debt-by-100-million-using-cash-generated-from-operations-301119974.html
SOURCE Bausch Health Companies Inc.